Patent Family

Home / Patent Family

IP:Critical Positions in Know-How, Trade Secret Assets for Expansive IP Portfolio


Positions of Patenting​

  • Drug-Drug​
  • Drug-Device​
  • Device-Device​

Strong IP Position in COMPOSITION OF MATTER and product by Process uniquely positioned

  • IP – Patent WO 2019/055489 A1 issued in March 2019; presently applying for other patents. ( 4 provisional )​
  • PCT in progress​
  • GMP - validated purification, stabilization and large volume scale up​
  • Freedom to operate​

Competition 

  • No direct competition - First in Class​
  • Verifiable source, Competitive production cost, FDA/EMA registration pathway identified (accelerated) 


© Matinicus Pharma  Site Made with ♥️ By Gossh Expert 2xN

For further information on OXY-Rx™ please contact us.

We would be happy to discuss it further.

0207 034 3300

We’d like to hear from you

Fitzrovia Hospital,

13-14 Fitzroy Square London, W1T 6AH

Please write to us

Contact us for further information

About

Matinicus Pharma provides life-sustaining support and resuscitation for local (tissue, organ) and systemic (body) oxygen deprivation.

Press Releases


Contact

0207 034 3300


Fitzrovia Hospital,

13-14 Fitzroy Square London, W1T 6AH